Archives: Speakers

Douglas Geertz is the Founder & CEO of Vidya AG, a private office for investing and consulting. Prior to engaging in his entrepreneurial activities, Douglas was a highly successful global corporate executive – CEO Tetra Pak Switzerland; CEO Tetra Pak Chile; Managing Director Tetra Pak Asia & Americas / Deputy MD Tetra Pak Hong Kong / Chairman of the Board / Founding Member Swedish-Chilean Chamber of Commerce / Area Manager Atlas Copco International  Africa and Latin America markets / Marketing & Sales Saab Aerospace / Marketing Manager Swedish-Brazilian Chamber of Commerce. Building on his extensive knowledge in different industries and cultures he now passionately builds, connects, and capitalizes great businesses around the world, including ventures in agroforestry and timber in Brazil and China.

Shari leads the company’s flavor technology and product development activities, focusing specifically on working directly with clients to deliver great tasting, healthier food and beverage options for their consumers and expanding and strengthening their brand position.

Prior to joining Sweegen in 2018, Shari held various executive roles in the flavor industry focusing on domestic and global innovation with a proven track record in commercializing flavor and ingredient technologies.

Shari has been a successful senior leader in product and process development, global innovation and business development for 32 years and worked for Brown Forman, Flavorman, Sensient, Firmenich, Mane, Senomyx and Chromocell.

Shari received her Bachelor of Arts in Chemistry from Bellarmine University in Louisville, Kentucky and an Executive MBA from Rider University in Lawrenceville, NJ.

Education: Engineer in Agronomy, Food product & process

Current: Business development Manager Sweetness for the last 3 years, in charge of full-, low- & no- calorie sweeteners

Previous: 25 years in Product development & Strategic Sourcing in EU & Global FMCG

Angela Luttick is a virologist with more than 20 years’ experience in the discovery, development and commercialisation of novel drugs. Well accustomed to leading multidisciplinary teams and experienced in the generation and integrity of key discovery-stage biological data required for the preparation of IND packages used in filing numerous FDA submissions. Angela is a co-founder and executive director at 360biolabs and leads business development and strategy for company growth.

Cameron Johnson is considered one of the most experienced Phase I Clinical Trial professionals in Australia, having held senior management roles within three of the four established Phase I Australian Clinical Trial companies.

Cameron’s Phase I experience extends into Europe and the Clinical Research Organization (CRO) industry, where he managed Clinical Trial facilities across Australia and New Zealand. He joined Nucleus Network in September 2013 as Chief Operating Officer before moving into the position of Chief Executive Officer (CEO) in May 2016.